INTARCIA THERAPEUTICS, INC — Form D/A

INTARCIA THERAPEUTICS, INC of HAYWARD, CA, a company, filed a Form D amendment with the SEC on 2011-08-25. The offering totals $44.0M, of which $40.3M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (75)

Showing 25 of 75 people.

NameRoleLocation
Kurt L GravesDirectorHayward, CA
K. Alice LeungDirectorHayward, CA
Ed L MathersDirectorNew Haven, CT
James L NiedelDirectorNew York, NY
Bryan L RobertsDirectorPleasanton, CA
Glen L SatoDirectorPalo Alto, CA
Irwin L ScherDirectorGaithersburg, MD
James Alice AhlersExecutive OfficerHayward, CA
Thomas L AlessiExecutive OfficerHayward, CA
David J FranklinExecutive OfficerHayward, CA
K. Alice LeungExecutive OfficerHayward, CA
Kenneth L LuskeyExecutive OfficerHayward, CA
Barbara L McClungExecutive OfficerHayward, CA
Michael WilliamsExecutive OfficerNew York, NY
John YeeExecutive OfficerSarasota, FL
Jay SkylerDirectorMiami Beach, FL
Bryan RobertsDirectorBoulder, CO
James AhlersExecutive OfficerHayward, CA
Gino SantiniDirectorCambridge, MA
Kurt GravesDirectorHayward, CA
Kurt GravesExecutive OfficerHayward, CA
David FranklinExecutive OfficerGainesville, FL
Jay SmithExecutive OfficerDavis, CA
PATRICK CONWAYDirectorTACOMA, WA
Barbara G McClungExecutive OfficerBerkeley, CA

Other filings by this issuer (18)

Showing 15 of 18 filings.

FiledFormOfferingSold
2020-01-14D/A$280.0M$198.5M
2019-03-12D$150.0M$73.1M
2017-08-04D/A$850.0M$524.6M
2017-04-03D/A$650.0M$475.7M
2017-01-13D$4K$4K
2017-01-06D/A$650.0M$390.7M
2016-09-15D$600.0M$184.4M
2014-04-07D$200.0M$200.0M
2012-11-29D$160.0M$155.9M
2012-11-29D$7.9M$7.9M
2012-11-29D$699K$699K
2012-08-30D/A$47.5M$45.8M
2012-08-22D$7.3M$7.3M
2011-06-10D/A$29.0M$27.0M
2010-09-07D$15.0M$5.0M

More